BRCA2 and colorectal cancer: Furthermore, any breast-colorectal GWAS signal was less likely to be due to syndromic cases since all cases carrying BRCA1 or BRCA2 or known colorectal cancer susceptibility gene mutations were excluded from the GWAS.